doc. Mgr. Kamil Paruch, Ph.D.
Associate professor, Department of Chemistry
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. A08/322
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5477 |
---|---|
E‑mail: |
Total number of publications: 152
2014
-
Is checkpoint kinase 1 a suitable molecular target for sensitization of TP53-mutated leukemia and lymphoma cells to chemotherapy?
Year: 2014, type: Conference abstract
-
Nanostructured surface modifications for stem cell studie
Year: 2014, type: Conference abstract
-
New carbocyclic nucleosides: synthesis of carbocyclic pseudoisocytidine and its analogs
Tetrahedron Letters, year: 2014, volume: 55, edition: 27, DOI
-
Syntheses of 5´-amino-2´,5´-dideoxy-2´,2´-difluorocytidine derivatives as novel anticancer nucleoside analogs
Tetrahedron Letters, year: 2014, volume: 55, edition: 3, DOI
2013
-
Are Time-Dependent Fluorescence Shifts at the Tunnel Mouth of Haloalkane Dehalogenase Enzymes Dependent on the Choice of the Chromophore?
Journal of Physical Chemistry B, year: 2013, volume: 117, edition: 26, DOI
-
Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, year: 2013, volume: 23, edition: 22, DOI
-
Quantum Mechanical Scoring: Structural and Energetic Insights into Cyclin-Dependent Kinase 2 Inhibition by Pyrazolo[1,5-a]pyrimidines
Current Computer-Aided Drug Design, year: 2013, volume: 9, edition: 1
-
Synthetic lethality in p53 mutated B-cell mylignancies: Chk-1 inhibition and DNA-PK inhibition effect in cell lines and primary CLL cells
Year: 2013, type: Conference abstract
2012
-
Cyclin-dependent kinase Inhibitors Inspired by Roscovitine: Purine Bioisosteres
CURRENT PHARMACEUTICAL DESIGN, year: 2012, volume: 18, edition: 20
-
Inhibice kinázy Chk1 senzitivuje buňky leukemií a lymfomů s mutacemi p53 na chemoterapeutika
Year: 2012, type: Conference abstract